Associate Director, Indication Marketing Lead, Cutaneous Melanoma

Location of role

Gaithersburg, MD

Commercial

MAIN PURPOSE OF JOB

Reporting to the Head of US Marketing, the Associate Director, Indication Marketing Lead, Cutaneous Melanoma (CM) – US is responsible for developing and leading efforts to craft and execute promotional tactics to support approval and commercialization for the potential indication of KIMMTRAK (Tebentafusp) in 2L+ metastatic Cutaneous Melanoma (mCM).

• Support the development of US marketing strategic and operational plans for pre-launch / launch efforts for the potential indication of KIMMTRAK in CM.
• Ensure successful execution of compelling pre-launch and market development activities for US HCPs across personal and non-personal channels.
• Develop and align messaging platform and tactical rollout with brand objectives and strategies
• Ensure key brand messages and materials are effectively communicated at sales meetings
• Support management of the promotions budget, establish goals and metrics, and measure performance
• Collaborate effectively with cross-functional partners, including field sales, sales training, market planning, and regulatory/compliance
• Collaborate with the US Marketing team (US Omnichannel Marketing Lead, US KOL & Peer-to-Peer Lead, and US Integrated Marketing Execution Lead) to develop promotional materials targeting HCPs, patients, caregivers, and Advanced Practice Providers.
• Manage key vendor relationships, including the promotional agency of record
• Embrace an HPT (High Performance Team) and Growth Mindset by fostering trust and a strong culture across the broader marketing and sales teams and with partners throughout the organization
• Ensure compliance with all laws, regulations, and policies that govern Immunocore.
• Ensure alignment with the overarching US Marketing Strategy for KIMMTRAK across both indications (UM and CM) and provide support as needed to UM Marketing activities.

• Master’s degree in related discipline and 9 years of related Medical, Scientific or Healthcare experience; or
• BS/BA degree in related discipline and at least 11 years of related Medical, Scientific or Healthcare experience; or
• Equivalent combination of education and experience

• Experience in product marketing, field sales or market research/analysis in the pharmaceutical or biotech industries
• Biotech / Pharmaceutical Marketing
• Basic understanding of the communication regulations for CFL and SIUU per the FDA
• Product launch experience strongly preferred
• Oncology experience strongly preferred
• Patient Marketing, advocacy relations, public relations, digital marketing and sales experience are a plus

• Advanced prioritization skills and ability to handle multiple projects
• Comprehensive ability to collaborate with multiple organizational stakeholders
• Advanced talent for blending innovation with pragmatic execution
• Intermediate skills to network internally and externally
• Advanced ability to draw insight from market research, the sales force, and other sources to optimize messaging, tactical plans, and promotional activities
• Advanced strategic thinking, initiative and creativity
• Advanced track record for consistently meeting or exceeding financial and/or other quantitative targets, as well as qualitative goals
• Advanced presentation, verbal and written communication skills
• Advanced understanding of FDA Regulations of pharmaceutical drug promotions and experience with Legal, Medical and Regulatory review process

Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech industry’s most successful drug developers. We are creating not just an environment where great minds can interact but an innovation powerhouse answering the big questions.

Focused on delivering first-in-class biological therapies to patients, we have developed a highly innovative soluble TCR…